With over 35 years in the pharmaceutical and bioscience industries, Lusia is an experienced company Director, former CEO, technology developer and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the Manufacturing Division of pharmaceutical company FH Faulding & Co (now Mayne Pharma). Lusia then went on to found medical technology innovation company LBT Innovations Limited (ASX:LBT) where she was Chief Executive Officer and Managing Director until 2016 and Chair of Clever Culture Systems, Zurich (LBT’s European joint venture company) until 2018.
Lusia currently serves as Chair of Neo-Bionica, Chair of BioMelbourne Network and as Independent Director at WearOptimo. Lusia is also a Non-Executive Director of 4DMedical (ASX:4DX) and is Chair of 4D Medical’s wholly owned subsidiary ALHI (Australian Lung Health Initiative).
She is a member of Industry Advisory Committees for the Australian Regenerative Medicine Institute, the Australian Institute for Machine Learning and Swinburne Manufacturing Futures Research Institute.
Lusia has a proven track record in bringing innovative products to global markets. She has an ongoing interest in the commercialisation of innovative healthcare products that incorporate automation, machine learning and artificial intelligence.